Virios Stock Story

Virios Stock News module provides quick insight into current market opportunities from investing in Virios Therapeutics. Use historical and current headlines to determine the investment entry and exit points. Many technical investors use Virios Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Check out World Market Map.
  
Refresh
Virios Therapeutics stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Virios daily returns and investor perception about the current pice of Virios Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Purchase by De La Rosa Abel of 4000 shares of Virios Therapeutics
Filed transaction by Virios Therapeutics Inc director. General open market or private purchase of non-derivative or derivative security

Virios insider trading alert for perchase of common stock by De La Rosa Abel, the corporate stakeholder, on 7th of January 2022. This event was filed by Virios Therapeutics Inc with SEC on 2022-01-07. Statement of changes in beneficial ownership - SEC Form 4
Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker

Virios Therapeutics Fundamental Analysis

We analyze Virios Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Virios Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Virios Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Ratio

Current Ratio Comparative Analysis

Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.

Peers

Your Trending Equities

AAL  7.67   
0%
100.0%
C  7.56   
0%
98.0%
AA  5.18   
0%
67.0%
WFC  3.55   
0%
46.0%
INTC  3.06   
0%
39.0%
AAPL  2.54   
0%
33.0%
IBM  2.47   
0%
32.0%
S  2.41   
0%
31.0%
MET  2.15   
0%
28.0%
UPS  1.87   
0%
24.0%
HD  1.68   
0%
21.0%
T  1.43   
0%
18.0%
CVS  0.84   
0%
10.0%
CVX  0.59   
0%
7.0%
BBY  0.32   
4.0%
0%
TGT  1.81   
23.0%
0%
Check out World Market Map. Note that the Virios Therapeutics information on this page should be used as a complementary analysis to other Virios Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Tools for Virios Stock

When running Virios Therapeutics price analysis, check to measure Virios Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Virios Therapeutics is operating at the current time. Most of Virios Therapeutics' value examination focuses on studying past and present price action to predict the probability of Virios Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Virios Therapeutics' price. Additionally, you may evaluate how the addition of Virios Therapeutics to your portfolios can decrease your overall portfolio volatility.
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Go
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Go
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Go
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Go
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Go
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go